High PD-L2 was associated with worse patient survival outcomes, as noted in hepatocellular carcinoma [28,54], colorectal cancer [55], and renal cell carcinoma [56]. Here, PDCD1LG2 is linked to hereditary clear cell renal cell carcinoma.